Immuno-oncology is one of the fastest growing and most exciting branches of modern medicine. It brings together two of the most important fields of medicine - immunology and oncology - to offer new approaches to cancer treatment that are based on activating and boosting the patient's immune system to fight tumours. This innovative field is already changing the fundamentals of cancer treatment, giving new options to patients who previously had no effective alternatives.

What is immuno-oncology?

Immuno-oncology is a scientific discipline that studies the ways in which the immune system can be used to treat cancer. Traditional treatments such as surgery, chemotherapy and radiation destroy cancer cells, but they also damage the body's healthy cells. Immunotherapy, on the other hand, uses the immune system's natural abilities to recognize and eliminate cancer cells, resulting in more precise and targeted treatment.

How does immuno-oncology work?

The body's immune system specialises in recognising and destroying foreign bodies, including viruses, bacteria and cancer cells. However, tumor cells often manage to evade immune surveillance through various mechanisms that render them invisible to immune cells. Immuno-oncology focuses on discoveries that help the immune system recognize these "invisible" cancer cells and attack them.

The main mechanisms used in immuno-oncology include:

1. Immune inhibitors: These drugs block the molecules that tumors use to suppress the immune response. For example, inhibitors of PD-1/PD-L1 or CTLA-4 allow immune cells to "release" their activity and attack cancer cells.
2. Monoclonal antibodies: These antibodies are synthetic molecules that bind to certain antigens on cancer cells and neutralize them. They can also stimulate the immune system to attack these cells.
3. Vaccine therapy: Immuno-oncology also includes vaccines that target the immune system against specific antigens associated with cancer cells. An example is the cervical cancer vaccine, which uses antibodies against the human papillomavirus (HPV), a major contributor to the development of cervical cancer.
4. CAR-T cell therapies (CAR-T): This is a revolutionary therapy in which a patient's T cells are taken and genetically modified in a laboratory to recognise and attack cancer cells. These modified cells are returned to the body where they fight the cancer.

What are the advantages of immuno-oncology?

Immuno-oncology offers significant advantages in cancer treatment compared to traditional methods:

1. Target Action: The immune system is more specific in recognizing cancer cells, which reduces damage to healthy cells. This results in fewer side effects compared to chemotherapy and radiation.
2. Long-term protection: Immuno-oncology has the potential to provide longer lasting protection against cancer. After a successful immune response, the immune system can "remember" tumor cells and attack them if they try to return to the body.
3. Suitable for various types of cancer: Immuno-oncology therapies are also extremely promising for a variety of cancers, including lung cancer, melanoma, bladder cancer, kidney cancer, lymphomas, and many others.
4. Personalized approach: Treatment with immuno-oncology therapies can be tailored to the individual patient and their genetic profile. This allows doctors to choose the most appropriate therapy that will have the greatest chance of success.

Problems and challenges in immuno-oncology

Despite significant progress, immuno-oncology still has its challenges:

1. Immune system reactions: Some patients may experience side effects from immunotherapies, such as autoimmune reactions in which the immune system begins to attack healthy cells and tissues.
2. Not all patients respond: Immunotherapies are not effective for all patients and not all cancers can be treated with immuno-oncology approaches.
3. Cost and accessibility: Immuno-oncology involves advanced and expensive therapies that may not be available to all patients or health systems worldwide.

The future of immuno-oncology

Immuno-oncology is at the very beginning of its development, and although it has already made significant progress, its future looks promising. There is new research into combining immunotherapy with other forms of treatment, such as chemotherapy and targeted therapies, which could lead to even more successful outcomes. In addition, efforts continue to discover new molecules and therapeutic approaches to make immuno-oncology more accessible and effective for all patients.

Conclusion

Immuno-oncology is poised to revolutionize cancer treatment by offering new and more effective treatment options that harness the immune system's own powers. Despite the challenges that lie ahead, advances in this field are giving hope to millions of patients around the world, giving them a chance for a better future without cancer. The possibilities of immuno-oncology will only grow, and with them the chance of success in the fight against cancer.